-transparent.png){kind=logo}
Hepatitis C virus (HCV), the major causative agent of post transfusion non-A, non-B hepatitis (NANB), had been cloned and expressed. According to the protein sequence of HCV-BK and its epitope profiles which combined the hydrophilicity, accessibility, flexibility, antigenicity, charge distribution and HPLC reserve coefficient of protein using the "Goldkey" computer program, we designed and synthesized the following peptides: P1(475-495), P3(449-468), P4(658-663), P5(645-663), P6(484-489), P7(475-489), P15(655-662), P16(230-237), P17(225-237), P18(1220-1240), P19(1694-1735), P24(1230-1240), P25(1482-1493), P26(384-389), P27(2355-2389). The results of ELISA showed that P6(60% positive results) and P19(63% positive results) testing with PT-HC of Gu An, Hebei province were the major antigens in NS1 and in NS4 region, respectively.
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
January 2009,
Biomeditsinskaia khimiia,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
January 1992,
Archives of virology. Supplementum,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
May 1992,
Proceedings of the National Academy of Sciences of the United States of America,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
April 1963,
The Journal of biological chemistry,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
October 1998,
FEBS letters,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
July 2015,
Vaccine,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
September 1999,
Vaccine,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
October 1995,
Journal of virological methods,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
January 2021,
PloS one,
G Liu, and
Z L Liang, and
M S Cai, and
H Zhuang, and
J P Guo, and
Q M Tao
October 1962,
The American review of respiratory disease,
